EP0536234A4 - Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof - Google Patents
Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereofInfo
- Publication number
- EP0536234A4 EP0536234A4 EP19910912130 EP91912130A EP0536234A4 EP 0536234 A4 EP0536234 A4 EP 0536234A4 EP 19910912130 EP19910912130 EP 19910912130 EP 91912130 A EP91912130 A EP 91912130A EP 0536234 A4 EP0536234 A4 EP 0536234A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- packaging
- vectors
- hiv
- sequences
- defective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000004806 packaging method and process Methods 0.000 title 2
- 239000013598 vector Substances 0.000 title 2
- 230000002950 deficient Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16051—Methods of production or purification of viral material
- C12N2740/16052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54074690A | 1990-06-20 | 1990-06-20 | |
US540746 | 1990-06-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0536234A1 EP0536234A1 (en) | 1993-04-14 |
EP0536234A4 true EP0536234A4 (en) | 1993-09-15 |
Family
ID=24156769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19910912130 Withdrawn EP0536234A4 (en) | 1990-06-20 | 1991-06-18 | Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0536234A4 (ja) |
JP (1) | JP3264281B2 (ja) |
CA (1) | CA2084659A1 (ja) |
WO (1) | WO1991019798A1 (ja) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5861282A (en) * | 1989-10-16 | 1999-01-19 | Whitehead Institute For Biomedical Research | Non-infectious HIV particles and uses therefor |
DK0630409T3 (da) * | 1992-02-28 | 2003-03-24 | Syngenix Ltd | Defekt-pakkende ikke-onkovirus-vektorer baseret på MPMV |
EP0633942A1 (en) * | 1992-03-27 | 1995-01-18 | Whitehead Institute For Biomedical Research | Non-infectious hiv particles and uses therefor |
EP0644946A4 (en) * | 1992-06-10 | 1997-03-12 | Us Health | VECTOR PARTICLES RESISTANT TO HUMAN SERUM INACTIVATION. |
WO1994016736A1 (en) * | 1993-01-22 | 1994-08-04 | University Research Corporation | Localization of therapeutic agents |
US6013516A (en) * | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
US6242187B1 (en) | 1996-01-29 | 2001-06-05 | Virologic, Inc. | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
US5837464A (en) * | 1996-01-29 | 1998-11-17 | Virologic, Inc. | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
US6200811B1 (en) * | 1996-04-02 | 2001-03-13 | The Regents Of The University Of California | Cell transformation vector comprising an HIV-2 packaging site nucleic acid and an HIV-1 GAG protein |
US7198784B2 (en) | 1996-10-17 | 2007-04-03 | Oxford Biomedica (Uk) Limited | Retroviral vectors |
WO1999032646A1 (en) | 1997-12-22 | 1999-07-01 | Oxford Biomedica (Uk) Limited | Equine infectious anaemia virus (eiav) based |
CZ137399A3 (cs) * | 1996-10-17 | 1999-07-14 | Oxford Biomedica (Uk) Limited | Retrovirový produkční systém pro produkci replikačně defektivních vektorovýh partikulí |
US6218181B1 (en) | 1998-03-18 | 2001-04-17 | The Salk Institute For Biological Studies | Retroviral packaging cell line |
WO2001007646A2 (de) * | 1999-07-21 | 2001-02-01 | Martin Heinkelein | Verfahren zur quantifizierung der antiviralen wirkung antiviraler wirkstoffe |
GB0108065D0 (en) * | 2001-03-30 | 2001-05-23 | Syngenix Ltd | Viral vectors |
WO2005118809A2 (en) * | 2004-04-29 | 2005-12-15 | The University Of North Carolina At Chapel Hill | Methods and compositions for enhancing cell adhesion properties |
-
1991
- 1991-06-18 CA CA002084659A patent/CA2084659A1/en not_active Abandoned
- 1991-06-18 EP EP19910912130 patent/EP0536234A4/en not_active Withdrawn
- 1991-06-18 JP JP51128291A patent/JP3264281B2/ja not_active Expired - Lifetime
- 1991-06-18 WO PCT/US1991/004335 patent/WO1991019798A1/en not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
No further relevant documents disclosed * |
Also Published As
Publication number | Publication date |
---|---|
JP3264281B2 (ja) | 2002-03-11 |
EP0536234A1 (en) | 1993-04-14 |
WO1991019798A1 (en) | 1991-12-26 |
CA2084659A1 (en) | 1991-12-21 |
JPH05508320A (ja) | 1993-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2245254B (en) | Packaging | |
EP0536234A4 (en) | Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof | |
AU8830591A (en) | Packaged article | |
NZ238552A (en) | Benzodiazepin-2-amine derivatives; preparatory processes, use, and medicaments | |
GB8901319D0 (en) | Packaging | |
GB2232686B (en) | Heat-shrinkable article | |
GB2265314B (en) | Protective articles. | |
GB2227226B (en) | Overtape-sealed bag | |
GB2231027B (en) | Bags | |
US4895456B1 (en) | Shopping bags | |
GB9026946D0 (en) | Packaging | |
GB8926465D0 (en) | Bags | |
GB8925310D0 (en) | Packaging | |
GB9304963D0 (en) | Vest type carrier bag | |
GB2231556B (en) | Packaging | |
ZA902869B (en) | Novel peptides,and antidementia agents containing the same | |
NZ240927A (en) | Dibenz-oxa-thiocinones; preparatory processes, uses, and pharmaceutical compositions | |
AU118993S (en) | Bag/shirt | |
GB8927960D0 (en) | Packaging articles | |
CA66807S (en) | Bag carrier | |
AU110179S (en) | Carrying bag | |
GB9210028D0 (en) | Inflatable protective clothing(packaging) | |
GB8906577D0 (en) | Carrier bag | |
GB9001112D0 (en) | Packaging | |
GB9009749D0 (en) | Packaging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19921127 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19930730 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Withdrawal date: 19931008 |